FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123561844> ?p ?o ?g. }

• W2123561844 endingPage "466" @default.
• W2123561844 startingPage "455" @default.
• W2123561844 abstract "Introduction: Therapeutic peptides in inflammatory bowel diseases essentially comprise cytokines affecting immune response, growth factors and monoclonal antibodies directed against key targets of mucosal inflammation, in particular, tumor necrosis factor-α (TNF-α). The latter have revolutionized standard medical treatment which previously was restricted to mesalamine, corticosteroids or classical immunosuppressants. Areas covered: We review current evidence of the use of the so-called biologicals, including the well-established TNF-α antagonists and novel peptides and monoclonal antibodies developed for these diseases. The focus is on controlled clinical trials and meta-analyses, if available. Limitations and biases of these studies are important but tend to be ignored. Safety is also an important issue with opportunistic infections and lymphoma as relevant risks. There is significant heterogeneity between different countries, guidelines and opinions within the scientific community regarding clinical indications, even apart from pharmacoeconomics and reimbursement. Expert opinion: TNF blockers have greatly extended medical options in inflammatory bowel diseases. Their more or less extensive use in nearly all patients or only a few selected indications is a matter of debate. It proved difficult to reproduce this success with other antibody targets as well as with immunomodulatory cytokines and growth factors. The most promising novel peptide is vedolizumab, an antibody against α4β7 integrin." @default.
• W2123561844 created "2016-06-24" @default.
• W2123561844 creator A5029630686 @default.
• W2123561844 creator A5042126639 @default.
• W2123561844 creator A5051427237 @default.
• W2123561844 date "2014-01-23" @default.
• W2123561844 modified "2023-09-25" @default.
• W2123561844 title "Therapeutic peptides in inflammatory bowel disease" @default.
• W2123561844 cites W1694206139 @default.
• W2123561844 cites W1964785646 @default.
• W2123561844 cites W1984705525 @default.
• W2123561844 cites W1986109277 @default.
• W2123561844 cites W1986933031 @default.
• W2123561844 cites W1987925515 @default.
• W2123561844 cites W1991810959 @default.
• W2123561844 cites W1995803004 @default.
• W2123561844 cites W1996476032 @default.
• W2123561844 cites W2000379621 @default.
• W2123561844 cites W2004057177 @default.
• W2123561844 cites W2005855555 @default.
• W2123561844 cites W2009025779 @default.
• W2123561844 cites W2010264478 @default.
• W2123561844 cites W2014257728 @default.
• W2123561844 cites W2018902013 @default.
• W2123561844 cites W2023078169 @default.
• W2123561844 cites W2024162533 @default.
• W2123561844 cites W2026116536 @default.
• W2123561844 cites W2029723826 @default.
• W2123561844 cites W2031860350 @default.
• W2123561844 cites W2034126900 @default.
• W2123561844 cites W2038535814 @default.
• W2123561844 cites W2047398409 @default.
• W2123561844 cites W2048323123 @default.
• W2123561844 cites W2054184323 @default.
• W2123561844 cites W2054710465 @default.
• W2123561844 cites W2059127937 @default.
• W2123561844 cites W2064275071 @default.
• W2123561844 cites W2077531651 @default.
• W2123561844 cites W2081061562 @default.
• W2123561844 cites W2081071002 @default.
• W2123561844 cites W2085127303 @default.
• W2123561844 cites W2088513474 @default.
• W2123561844 cites W2091587044 @default.
• W2123561844 cites W2092863985 @default.
• W2123561844 cites W2093985240 @default.
• W2123561844 cites W2100942700 @default.
• W2123561844 cites W2102087425 @default.
• W2123561844 cites W2102804688 @default.
• W2123561844 cites W2102897127 @default.
• W2123561844 cites W2104015736 @default.
• W2123561844 cites W2106315342 @default.
• W2123561844 cites W2111362292 @default.
• W2123561844 cites W2120522488 @default.
• W2123561844 cites W2121609590 @default.
• W2123561844 cites W2122247171 @default.
• W2123561844 cites W2126807394 @default.
• W2123561844 cites W2127693350 @default.
• W2123561844 cites W2131632358 @default.
• W2123561844 cites W2131882149 @default.
• W2123561844 cites W2132784721 @default.
• W2123561844 cites W2134590709 @default.
• W2123561844 cites W2137775651 @default.
• W2123561844 cites W2142514968 @default.
• W2123561844 cites W2143625465 @default.
• W2123561844 cites W2145436896 @default.
• W2123561844 cites W2146101488 @default.
• W2123561844 cites W2146692972 @default.
• W2123561844 cites W2152026434 @default.
• W2123561844 cites W2152381563 @default.
• W2123561844 cites W2162805528 @default.
• W2123561844 cites W2164861161 @default.
• W2123561844 cites W2166360124 @default.
• W2123561844 cites W2167152940 @default.
• W2123561844 cites W2168370388 @default.
• W2123561844 cites W2171297959 @default.
• W2123561844 cites W2171341132 @default.
• W2123561844 cites W2321453230 @default.
• W2123561844 cites W2326330820 @default.
• W2123561844 cites W4230184840 @default.
• W2123561844 doi "https://doi.org/10.1517/14712598.2014.880109" @default.
• W2123561844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24450849" @default.
• W2123561844 hasPublicationYear "2014" @default.
• W2123561844 type Work @default.
• W2123561844 sameAs 2123561844 @default.
• W2123561844 citedByCount "2" @default.
• W2123561844 countsByYear W21235618442014 @default.
• W2123561844 countsByYear W21235618442015 @default.
• W2123561844 crossrefType "journal-article" @default.
• W2123561844 hasAuthorship W2123561844A5029630686 @default.
• W2123561844 hasAuthorship W2123561844A5042126639 @default.
• W2123561844 hasAuthorship W2123561844A5051427237 @default.
• W2123561844 hasConcept C126322002 @default.
• W2123561844 hasConcept C159654299 @default.
• W2123561844 hasConcept C177713679 @default.
• W2123561844 hasConcept C17991360 @default.
• W2123561844 hasConcept C203014093 @default.
• W2123561844 hasConcept C2776207728 @default.
• W2123561844 hasConcept C2776215756 @default.

• next